Cite
Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study
MLA
E I, Braicu, et al. “Preoperative HE4 Expression in Plasma Predicts Surgical Outcome in Primary Ovarian Cancer Patients: Results from the OVCAD Study.” Gynecologic Oncology, vol. 128, no. 2, July 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8f170764d9e80885738cfe9c7318c363&authtype=sso&custid=ns315887.
APA
E I, B., C, F., T, V. G., R, R., R, C., C, H., H, B., D Cacsire, C.-T., S, M., R, Z., N, C., I, V., & J, S. (2012). Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study. Gynecologic Oncology, 128(2).
Chicago
E I, Braicu, Fotopoulou C, Van Gorp T, Richter R, Chekerov R, Hall C, Butz H, et al. 2012. “Preoperative HE4 Expression in Plasma Predicts Surgical Outcome in Primary Ovarian Cancer Patients: Results from the OVCAD Study.” Gynecologic Oncology 128 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8f170764d9e80885738cfe9c7318c363&authtype=sso&custid=ns315887.